*_number of visitors :   1232750 155 414 Visitor Tracker      Link to MRI e-mail       
staff

Curriculum Vitae view

Personal Details
Name :    Nadia Ahmed Abd El-Moneim Mohamed
Department :    Cancer Management and Research
Date of Birth :    27th October 1953
Country of Birth :    Egypt
Job :    Head of Department of Cancer Management & Research ,Professor of
E-mail :    mohamed_e_salem@hotmail.com, nadiaabdelmoneim@alex-mri.edu.eg,na

Affiliation
Cancer Management and Research Department , Medical Research Institute, University of Alexandria, Egypt .

Qualification
1- MD Degree in Internal Medicine, Department of Internal Medicine, Faculty of Medicine, Alexandria University, 1990.
1- M.Sc. degree in Internal Medicine, Department of Internal Medicine, Faculty of Medicine, Alexandria University, 1981.
2- MBBCH, Faculty of Medicine, Alexandria University,1976.

Appointments
1-August 2011-Current
Head of the Department of Cancer Management & Research ,Medical Research Institute, University of Alexandria, Egypt.
2-May 2008- July 2011
Professor of Clinical Oncology in Cancer Management and Research Department, Medical Research Institute, University of Alexandria, Egypt.

3-Oct 2007- May 2008
Head of Radiation Sciences Department, Medical Research Institute, University of Alexandria, Egypt.
4- Jan 2001- Oct 2007
Professor of Clinical Oncology, Clinical Oncology Unit, Radiation Sciences Department, Medical Research Institute, University of Alexandria, Egypt.

5- Dec 1995- Jan 2001
Assistant Professor of Clinical Oncology, Clinical Oncology Unit, Radiation Sciences Department, Medical Research Institute, University of Alexandria, Egypt.

6-Nov 1990- Dec 1995
Lecturer in Clinical Oncology Unit, Radiation Sciences Department, Medical Research Institute, University of Alexandria, Egypt.

7-Jan 1984- Nov 1990
Assistant Lecturer in Clinical Oncology Unit, Radiation Sciences Department, Medical Research Institute, University of Alexandria, Egypt.

8-Apr 1982- Jan 1984
Demonstrator in Clinical Oncology Unit, Radiation Sciences Department, Medical Research Institute, University of Alexandria, Egypt.

9- Dec 1978- Dec 1981
Resident of Internal Medicine, Faculty of Medicine, Alexandria University, Egypt.

10- Mar 1978- Nov 1978
Physician in the Ministry of health, Egypt.

11- Mar 1977- Feb 1978
House Officer in the Faculty of Medicine, University of Alexandria.,Egypt.

Courses, Meetings & Conferences
Courses:
• Radiobiology course for PH D degree in Radiation Sciences, Department of Radiation Sciences, Medical Research Institute, University of Alexandria, Egypt.
• Molecular Biology of Cancer course for PH D degree of Biotechnology Department of Biotechnology, Institute of Graduate Studies and Research, University of Alexandria, Egypt.
(Elective course 3 credit hours)
• Nuclear Medicine course for Master degree in Radiation Sciences, Department of Radiation Sciences, Medical Research Institute, University of Alexandria, Egypt.
• Oncology Course for Diploma Degree in Breast Cancer Imaging , Department of Radiodiagnosis, Medical Research Institute, University of Alexandria, Egypt.


Conferences and Meetings:
• The Egyptian Association of Advancement of Medical Basic Sciences ,Faculty of Medicine ,Alexandria University, I got a Certificate of achievement in 2 June 2013 for my paper " Hewala TI, Abd El-Moneim NA, Ebied SA, Sheta MI, Soliman K, Abu–A Elenean. Diagnostic and prognostic value of serum nitric oxide, tumor necrosis factor–α, basic fibroblast growth factor and copper as angiogenic, markers in premenopausal breast cancer patients : a case control study. J Br Biomed Sci 2010; 67(4):167-76.

• Military Medical Academy Oncology Conference " Breast Cancer Update" 23 MAY 2013 Alexandria Military Hospital , Moustafa Khamel ,Alexandria, Egypt.
This meeting is accredited with 3 Hours of CME from Alexandria Medical Accreditation Council.
• WORKSHOP: Quality Assurance Unit, Medical Research Institute, Alexandria University, about "Research Ethics "by Prof Dr Azza Saleh ,Certified International Trainer of Research Ethics,USA,22 May 2013.


• The annual Oncology Meeting of Alexandria Society for Cancer Patient Care In association with Alexandria Clinical Oncology Department (ACOD) " TARGETED THERAPY : ACTION & PROTECTION " 1-3 MAY , Hilton Green Plaza Hotel –Alexandria , EGYPT .
I was a chairperson in the workshop" Nutrition &nCytotoxic drugs in Oncology " from 9:30-12:oo a m Friday , 3 rd May , 2013.
• The 10 th Annual Meeting of Mansoura Clinical Oncology & Nuclear Medicine department " EXPANDING FORNTIERS OF BREAST CANCER MANAGEMENT "DUSIT THANI HOTEL CAIRO _EGYPT ,10-11 APRIL 2013.I was one of the scientific committee and I shared by poster presentation Titled "
Molecular Diagnosis of Gene Polymorphism Affecting Melatonin Receptor Among Egyptian Breast Cancer Patients .

• scientific conference of National Cancer Institute (NCI) 45 years against cancer in Egypt "Updates on Breast and GIT cancer" held 3-5th April, 2013, Grand Nile Hotel ,Cairo, Egypt.
I shared by poster presentation Titled "
"A study of serum levels of vitamin D, ionized calcium and phosphorus in Egyptian breast cancer females: A Case Control Study"

• 5Th Breast – Gynacological International Cancer Conference BGICS ,17-18 January 2013, Fairmont Towers Hotel,Cairo,Egypt.
This meeting is accredited with 19 ESMO- MORA category points.A Poster Presentation was presented Titled:
Elalfy E, Abd El-Moneim NA, Khalil SA
. Impact of comorbidity, hormonal receptor status and Adjuvant chemotherapy plus tamoxifen versus tamoxifen, alone on survival of senior breast cancer patients: retrospective study Updated Data . The poster was recognized as the best research in the conference & got BGICS Research 1st award .

• Novartis Oncology Development Excellence (NODE),How to write an effective medical article (1.3 credit point ),The Accreditation Review Committee (ARC) of The American Academy of Continuing Medical Education (AACME) “ 28-29 November ,2012 Hilton Green Plaza –Alexandria, Egypt.
• 17th Conference “5th International “ Medical Research Institute –Alexandria University- advances in Medical Research ,”Obesity “13th-16th November,2012,Hilton Green Plaza Hotel, Alexandria ,Egypt.
• 7th SEMCO-ASCO Conference & Advanced Course .” Cancer care of the Older Population “.October 18-19 , 2012.Radisson Blue hotel , Cairo, Egypt.
• 15th annual International scientific conference of Alexandria Clinical Oncology Department (ACOD),”Cancer management : Options and Promising directions “10-12 October 2012,Helnan Palestine Hotel , Alexandria , Egypt.
• The Oncology Meeting of Alexandria Society of Cancer Patient Care In Association with Alexandria Clinical Oncology Department (ACOD) “Targeted Therapy : Cons & Pros “ 16-18 May ,2012 Hilton Green Plaza –Alexandria, Egypt.
• 14th annual International scientific conference of Alexandria Clinical Oncology Department (ACOD),”Recent updates in the management of breast Cancer “26-28 October 2011, Four Seasons Hotel , Alexandria , Egypt.
• Alexandria Faculty of Medicine, Alexandria Clinical Oncology Department (ACOD), in association with The Annual Oncology Meeting of Alexandria Society for Cancer Patient Care.” GIT Tumors Updates “10-12 Nov.2010, Helnan Palestine Hotel, Alexandria, Egypt .
• 16th Conference “4th International “ Medical Research Institute –Alexandria University- advances in Medical Research ,”Quality in Medical Education and Practice “19th -22rd October ,2010,Sheraton Montazah Hotel, Alexandria ,Egypt.
• 13th Annual International scientific Conference of Alexandria Clinical Oncology Department (ACOD) in association with ICEDOC and SEMCO “Personalizing Cancer Care “14-16 April 2010, Helnan Palestine Hotel, Alexandria, Egypt.
• 15th Conference 3rd International Medical Research Institute –Alexandria University.” advances in Medical Research ,”From molecular medicine …….to clinical applications”.20th -23rd October ,2009,Sheraton Montazah Hotel, Alexandria, Egypt.

• 12th Annual International Alexandria Oncology Conference SEMCO/ AORTIC/ ACOD Conference with EASO Day "Exploring New Avenues in Tailoring Cancer Treatment ACOD 12"13th-16th January 2009,Helnan Palestine Hotel, Alexandria, Egypt.
• Advance in Medical Research “Oncology” From bench to bedside, 14th Conference (2nd International) of the Medical Research Institute29th- 31st Oct. 2008, Alexandria, Egypt.
• 22nd International Medical Convention of National Arab American Medical Association in Collaboration with Alexandria Faculty of Medicine. "New Advances in Early Detection and Management of Cancer; Breast, Lung, Prostate and Pediatric". 1-3 Jul. 2008, Alexandria, Egypt.
• 1st Annual Alexandria National Breast Cancer Symposium (ANBCS). 19-20th June 2008, Alexandria, Egypt.
• 11th Annual International Alexandria Clinical Oncology Department Conference (ACOD11) in collaboration with SEMCO, ESMO and EASO. Dec 2007, Alexandria, Egypt.
• 8th International Conference of Oncology "Gastrointestinal Malignancies" Faculty of Medicine, Suez Canal University. Apr 2004.
• 7th International Conference of Oncology "Breast Cancer current status and future prospect", Faculty of Medicine, Suez Canal University. Apr. 2003.
• 6th International Conference of Oncology, Surgery and Gastroenterology "Towards a healthy liver", Faculty of Medicine, Suez Canal University. Apr. 2002.
• 2nd Mansoura Oncology and Nuclear Medicine Conference "Recent Advances in Oncology", April 2001.
• 5th International Conference of Oncology in Collaboration with ESO "Breast Cancer", Faculty of Medicine, Suez Canal University. March 2001.
• 15th Annual Scientific Conference, Faculty of Medicine, Tanta University 5-7th Apr. 2000.
• "The New Frontiers in Cancer Management" NEMROCK Annual Meeting in Collaboration with Harvard University Hospitals. 30-31 Mar 2000.
• The ASCO-PANARAB Conference on "Malignant Lymphoma and Evaluating the Role of Stem Cell Transplantation", 9-11th Nov. 1999.
• 1st Middle East Conference on "Recent Advances in the Management of Cancer'" Medical Research Institute, Alexandria. 20-22nd Oct 1999.
• 3rd Alexandria Oncology Conference and the European School of Oncology (ESO) Course 13-15th Oct 1999.
• 1st International Congress of the Egyptian Society of Hepatology, Gastroenterology, and Infectious Diseases. 21-23rd Apr 1999.
• 3rd International Conference of Oncology "Recent Advances in Diagnosis and Management of Cancer", Ismalia Faculty of Medicine. 16-18th Apr. 1999.
• 14th Annual Medical Conference. Faculty of Medicine, Tanta University, 7-9th Apr. 1999.
• 12th Annual Meeting of Egyptian Society of Hepatology and 1st Bulletin Congress of Alexandria, Faculty of Medicine, 25-27th Nov 1998
• 22nd Annual Congress "Update of Liver Diseases", Alexandria Medical Association and Tropical Medicine Alexandria University. 22nd Oct. 1998.
• 2nd Alexandria Oncology Conference (Recent Advances in Malignant Lymphomas and Breast Cancer) 30th Sep-2nd Oct 1998.
• 8th Medical Research Institute Conference and the 4th Egyptian-Italian Workshop, 26-27th Oct1996.
• 43th Annual World Assembly of American College of Angiology. Barcelona, Spain. 16-21 Jun 1996.



Publications
1. Elalfy E, Abd El-Moneim NA, Khalil SA. Impact of comorbidity, hormonal receptor status and Adjuvant chemotherapy plus tamoxifen versus tamoxifen, alone on survival of senior breast cancer patients: retrospective study Updated Data .Poster Presentation:.in 5Th Breast – Gynacological International Cancer Conference BGICS ) ,17-18 January 2013, Fairmont Towers Hotel,Cairo,Egypt.The poster was recognized as the best research in the conference & got BGICS Research 1st award .
2. Hewala TI, Shehata GM, Hemida MA, Abd El-Moneim NA. Evaluation of the effectiveness of serum aromatase activity and tissue polypeptide specific antigen in the diagnosis of breast cancer and prediction of lymph node metastatic status. Ain Shams journal of Surgery 2012; 5(1) :155-64.
3. Ebeed SA, Abd-El-Moneim NA, Saad A, Zaher ER, Gaber O, Khamis S. Diagnostic and prognostic value of circulating tumor cells in breast cancer females. Alexandria Journal Of Medicine 2012; 48:197-206.
4. Hewala TI, Abd El-Moneim NA, Anwar MM, Ebied SA. The clinical significance of serum soluble fas and P53 in breast cancer patients: Comparison with serum CA 15-3. Pathol & Oncol Res DOI 10.1007/s12253-012-9512-1. 17 March 2012.
5. Abd El-Moneim NA, Khalil SA, Elalfy E. Impact of comorbidity, hormonal receptor status and Adjuvant chemotherapy plus tamoxifen versus tamoxifen, alone on survival of senior breast cancer patients: retrospective study. Poster Presentation: Poster# 89.in 11th Meeting of the International Society of Geriatric Oncology-SIOG; Cancer in Senior Adults - SIOG Conference Paris 2011, November 4– 5, 2011, Paris, France. Abstract Publication: Journal of Geriatric Oncology – JGO 2011;2 (Suppl 1): S57.
6. Khalil GI, Abd El-Moneim NA, Mohamed AH, Emara AA, Mohamed EI. Effects of Adjuvant Chemotherapy on body – composition and bone mineral density of Egyptian women with non metastatic breast cancer .The 9th International Symposium . on in Vivo Body Composition .Studies” Body Compositions And Biological Diversities .” Zhejiang University School of Public Health . The International Society for Body Composition Research And Chinese Preventive Medicine Association . Hangzhou China ,May 21-24 2011. Oral Presentation, also Abstract was published in International J of Obesity 2011; 25(Supp-2 016). Available at : www.nature.com/ijo
7. Hewala TI, Abd El-Moneim NA, Shehata GM .Risk factors of breast cancer in Egyptian postmenopausal females in Alexandria. 16th Conference “ 4rd International “ Medical Research Institute –Alexandria University. advances in Medical Research ,”Quality in Medical Education and Practice “19th -22rd October ,2010,Sheraton Montazah Hotel, Alexandria ,Egypt. Poster presentation, (Abstract book ) page 37& also published in Bulletin of high institute of public health 2011; 41(1):50-65.
8. Hewala TI, Ebied SA, Abd El-Moneim NA, El-Kholy SM , Yehia MAH, El-Feky SE. The radioprotective effect of green tea extract on gamma-irradiated mice. Isotopes and radiation research Bulletin 2010; 42 (3): 731-46.

9. Hewala TI, Shehata GM, Abd El-Moneim NA. Association of body mass index and serum adipocytokines with breast cancer risk in Egyptian premenopausal females in Alexandria. 16th Conference “ 4rd International “ Medical Research Institute –Alexandria University. advances in Medical Research ,”Quality in Medical Education and Practice “19th -22rd October, 2010,Sheraton Montazah Hotel, Alexandria ,Egypt. oral presentation, (Abstract book ) page 35. Published in Bulletin of Alexandria faculty of Medicine 2010; 46(4): 291-6..
10. Hewala TI, Abd El-Moneim NA, Ebied SA, Sheta MI, Soliman K, Abu–A Elenean. Diagnostic and prognostic value of serum nitric oxide, tumor necrosis factor–α, basic fibroblast growth factor and copper as angiogenic, markers in premenopausal breast cancer patients : a case control study. J Br Biomed Sci 2010; 67(4):167-76.
11. Ebied SA, Abd El-Moneim NA, Soliman K, Zaher ER, Soliman YA. Evaluation of the role of serum tissue inhibitor of matrix metalloproteinase 1(TIMP-1) in vascular endothelial growth factor (VEGF) induction and their role in prognosis of breast cancer patients. JMRI 2009;30(1):23-33.
12. Hewala TI, Ebied SA, Abd El-Moneim NA, Ramadan HS, El-Fekya SE. A study on the radioprotective effect of green tea extract in gamma-irradiated ehrlich carcinoma-bearing mice. JMRI 2009; 30(2): 98- 104.
13. Abd-El-Moneim NA, Ebid SA, Kazem A, Sad A, Mousa S, El-Abd E, et al. The role of angiogenesis assessment in the prognosis of breast carcinoma and in the evaluation of the therapeutic effect of “shark care” drug as an angiogenesis inhibitor.Turkish J Cancer 2008; 38(3): 123-34.
14. El-Gezeery A, Mahmoud N ,Moustafa A, Mahrous H, Mahmoud H, Abd El-Moneim NA. BRCA1 gene mutation in familial breast cancer. Turkish J Cancer 2008; 38(4): 167-74.
15. Hashishe MM, Abd El-Moneim NA, El-Sayed EH. Presymptomatic detection of breast cancer in females, genetic testing of BRCA1 and BRCA2 : It `s Your Choice.14th Conference “ 2nd International “ Medical Research Institute –Alexandria University. advances in Medical Research ,” Oncology “ From bench … to bedside . “29th -31th October, 2008,Sheraton Montazah Hotel, Alexandria ,Egypt. oral presentation, (Abstract book) page 81.
16. Mahmoud MM, Abdel Rahman EMH, Zaher ER, Abd-El-Moneim NA, Abd-Al-Baky MA. Evaluation of some biochemical markers used for diagnosis and follow up of metastatic and non-metastatic breast cancer. Egypt J Biochem Mol Biol 2006; 24: 505-28.
17. Mostafa M, Morsi MI, Hussein A, El-Abd E, Abd-El-Moneim NA. Evaluation of tumor necrosis factor-α (TNF- α), soluble P-Selectin (sP-Selectin), gamma- glutamyl transferase (GGT), glutathione S-transferase Pi (GSI-Pi) and alpha-fetoprotein (AFP) in patients with hepatocellular carcinoma before and during chemotherapy. Turkish J Cancer 2005; 35(1): 5-11.
18. Morsi Mi, Abd-El-Moneim NA, Hussain NG, Abd-Al-Rahman EMH, Abd-El-Baky MA. Soluble intracellular adhesion molecule-1 (sICAM-1), CA 15.3, glutathione (GSH) and glutathione S-transferase (GST) in different clinical stages of postmenopausal Breast cancer patients. Egyp J biochem Mol Biol 2005; 23: 226-37.
19. Hussein AE, Abd-El-Moneim NA, Mohmoud MM, Abdel-Baky MM. The role of interferon-gamma and vitamin A in modulating telomerase activity in breast cancer patients. Egypt J Immunol 2003; 10(1): 47-56.
20. Morsi MI, Abd-El-Moneim NA, El-Zoghby SM. Serum Insulin-like growth factor I (IGF-I) and its binding protein 3 (IGFBR 3) in relation to estrogen in postmenopausal patients with breast cancer receiving Tamoxifen with or without vitamin A. Med J Cairo Univer 2003; 71(3): 149-57.
21. Hamed NAM, Abdel Halim M, Abd-El-Moneim NA. Oxidative stress as a possible mechanism of resistance to Anthracycline-based regimens in acute leukemias: role of histamine in radical release from isolated leukemic monocytes. JMRI 2003; 24(2):26-39.
22. Kholeif SF, Mokhtar MM, Ibrahim MM, Abd-El-Moneim NA. Micronucleus assay in patients with lung cancer, chronic obstructive pulmonary disease and non-smoker control. Bull High Institute of Public Health 2002; 32(4):665-76.
23. El-Kholy S, Abdel Gawad S, Abd-El-Moneim NA, Said R. Study of the effects of Gamma-Ray and electromagnetic field on mice tissues injected by 5-flurouracil. JMRI 2001; 22(4):11-21.
24. Morsi MI, Abd-El-Moneim NA, Hassan AAM, Al-Sharaky AS. Radioimmunoassay of plasma glutathione s-transferase-Pi as a tumour marker in hepatocellular carcinoma. Bull Alex Fac Med 2001; 37(3):379-84.
25. Abd-El-Rehim WM, Soliman ASM, Abd-El-Moneim NA, Motawei MA. Alteration of erythocyte membrane lipids and adinosine triphosphatases in Breast Cancer Patients Treated with CMF: A Role of Antioxidant Supplementation. JMRI 2000; 21(2): 72-85.
26. Abd-El-Moneim NA, Attia MS, El-Shazly MK, Nagib MK. Psycho-social aspects of breast cancer patients. The First Middle East Conference on Recent Advances in the Management of Cancer. Medical Research Institute, University of Alexandriaand International Union Against Cancer (U.I.C.C) 20-22 Oct. Abstract book: 1999; 85.
27. Abd-El-Moneim NA, Abo-Shousha SA, Motawei MA, Hussein MZ. Granulocyte-macrophage-colony stimulating factor (GM-CSF) and interleukin-3 (IL-3) in Hodgkin's disease before and after treatment. Egypt J Immunol 1999; 6(2): 85-93.

28. Abd-El-Moneim NA, Demian SR, El-Sayed MH, Abdel-Baky MM. Cytokine patterns, neutrophil chemotactic activity, complement component-3 and circulating immune complexes relationship to clinical staging and treatment of breast cancer. JMRI 1999; 20(4): 33-47.
29. Hussein MZ, Abd-El-Moneim NA, Motawei MA, Abo El-Nazar SY. Interferon Îł ( IFN-Îł) Production in Malignant Lymphomas Before and After Treatment. JMRI 1999; 20(4):121-30.
30. Saad-El-Din S, Abd-El-Moneim NA, Morsy MI, El-Sedfy AS. Effect of long-term Tamoxifen on endometrium of postmenopausal breast cancer patients: Doppler sonograghy, Immunohistochemistry, Computerized image analysis and Hormonal profile. Med J Cairo Univer 1999; 67(4 Suppl): 433-46.
31. Abo-El-Nazar SY, Motawei MA, Abd-El-Moneim NA, Zoheir MA. Expression of intercellular adhesion molecule-1 (ICAM-1) in tissues and serum before and after treatment of colon carcinoma. Bull Alex Fac Med 1999; 35(4): 447-57.
32. Demian SR, Abd-El-Moneim NA. Evaluation of cytokines production and natural killer binding capacity in patients with hepatocellular carcinoma before and after chemotherapy. Egypt J Immunol 1998; 5 (1): 35-43.
33. Abd-El-Moneim NA, El-Sayed MA, Abdel-Baky MM, El-Shazly MK. Effect of chemotherapy on cytokine levels and monocytic activity in patients with gastrointestinal tract carcinomas. JMRI 1998; 19(2): 41-54.
34. Abd-El-Moneim NA, Hussein NG, Morsi MI, El-Kohly ZA, Shaheen NE, Abou-Raoash NM, et al. Effect of two chemotherapeutic regimens on some biochemical and immunological parameters in breast cancer patients. Med Sci Res (England) 1998; 26:301-7.
35. Helmy MH, Abd-El-Moneim NA, Abd-El-Baki MMA, El-Zoghby SM. The clinical value of serum lactate dehydrogenase, ceruloplasmin, cathepsin-D and lipid-bound sialic acid in monitoring patients with malignant lymphomas. Med Sci Res (England) 1998; 26: 613-7.
36. Abd-El-Moneim NA, Awad SI, Morsi MI, El-Zoghby SM. Alpha fetoprotein and hepatitis B virus markers in relation to liver cirrhosis and to hepatocellular carcinoma during chemotherapy. Bull Alex Fac Med 1997; 33(2): 223-30.
37. Megahed MA, Abd-El-Moneim NA, Abd-El-Baky MM. The effect of tamoxifen therapy on serum lipids, lipoproteins and lipid peroxides in postmenopausal women with breast cancer. Bull Alex Fac Med 1996; 32(3): 237-45.
38. Abd-El-Moneim NA, Abou-Diba MA, Youssef AI. Monitoring of malignant lymphoma patients by estimation of serum adenosine deaminase (ADA) and B glucuronidase (BG). JMRI 1996; 17(2): 26-35.
39. Rashwan EA, Abd-El-Moneim NA, Motawei MA. Interleukin-2 production and expression of interleukin -2 receptor by activated peripheral blood T-lymphocytes in Hodgkin's disease. JMRI 1996; 17(1) :157-66.
40. Abo El-Nazar SY, Abu-Deeba MI, Rashwan EA, Afifi MS, Abd-El-Moneim NA, Abdel-Salam M. evaluating serum levels of tumour necrosis factor alpha and interleukin -1 alpha in diagnosis and monitoring patients with non Hodgkin's lymphoma (NHL).JMRI 1995; 16(1):140-7.
41. Fikry NM, Abd-El-Moneim NA, Abdel Mawla AA. Effect of inducing 50 Hz sine shape electromagnetic field on the peripheral blood count and spleen structure of mice injected with cyclophosphamide. Egyptian J of Biophysics jan 1994; 94: 53-67.
42. Motawei MA, Abd-El-Moneim NA, El-Kholy SMI, Desouki A. Effect of Different therapeutic modalities on some trace elements in cancer breast. Bull Alex Fac Med 1994; 30(1): 81-8.
43. Abd-El-Moneim NA, Fahmy EI, Motawei MA, Bayoumi D, Abd El-Mohsen SE, Moussa SM. Serum prolactin (PRL) and carcinoembryonic antigen (CEA) relationship to clinical staging and histopathological data:Indicators of disease progression and response to treatment in cancer breast. JMRI 1994; 15(1):1-8.
44. Abd-El-Moneim NA, Sharaf IA, El-Kholy SM, Motawei MA. Beta-Glucuronidase activity, iron and zinc in human tissue and serum: Possible clinical indicators for colorectal carcinoma. Egypt J Med Sci 1994; 15(2): 409-21.
45. Rashad MM, Abd-El-Moneim NA, Awad EI, Mina BF. Evaluation of Ribonuclease and Arylsulphatase A in sera and tissue of cancer breast patients: as diagnostic and monitoring enzymatic markers. Egypt J Med Sci 1994; 15(2): 667-76.
46. Rashwan EA, Afifi MS, Abo El-Nazar SY, Motawei MA, Abd-El-Moneim NA. IL-2 induction of lymphokin-activated killer (LAK) in peripheral blood lymphocytes lysis of fresh autologous cancer breast cells. Bull Alex Fac Med 1994; 30(6):1500-7.
47. Guirguis RS, Moussa LM, Mohamedeen NM, Abu Seif HH, Abd-El-Moneim NA. Non-Hodgkin's lymphoma: an ultrastructural study. J Egypt Med Assoc 1992; 75(7-12): 259-72.
48. Fahmy EI, Moussa SM, Abd-El-Moneim NA, Abd El-Mohsen SE, Elzayat EAF, Moussa LM. Evaluation of the role of serum CA 19-9 and CEA in gastrointestinal malignancies. JMRI 1992; 13(2): 47-69.
49. Abd-El-Moneim NA, Moussa SM, Fahmy EI, Salem ME, Abd-El-Mohsen SE. B2 microglobin (B2-M) as tumor marker in lymphoproliferative disorders. Egypt J Med Sci 1992; 13(2): 437-46.
50. Fahmy EI, Moussa SM, Abd-El-Moneim NA, Salem ME, Abd El-Mohsen SE, Moussa LM. The value of serum thyroglobin (Tg) measurement in thyroid diseases including malignancies. Egypt J Med Sci 1992; 13(2): 427-35.
51. Rashwan EA, Afifi MS, Abo El-Nazar SY, Motawei MA, Abd-El-Moneim NA. IL-2 induction of lymphokin-activated killer (LAK) in peripheral blood lymphocytes lysis of fresh autologous cancer breast cells. Bull Alex Fac Med 1994; 30(6):1500-7.
52. Salem ME, Abd-El-Moneim NA, Khalil SA. The outcome of non-Hudgkin's Lymphoma associated with Schistosomiasis versus non-Hudgkin's Lymphoma alnoe. JMRI 1991; 12(3): 61-76.
53. Moussa L, Khalil SA, Salem ME, Abd-El-Moneim NA, Sherif M, Khalil S. Intensive combination chemotherapy in the treatment of malignant lymphoma with Vincristine, adrimycin and prednisolone (VAP). JMRI 1991; 12(3): 43-60.
54. Salem ME, Abd-El-Moneim NA, Moussa SM, Fahmy EI. The value of ascetic fluid CEA as tumour marker in the differentiation of malignant and cirrhotic ascites. JMRI 1991; 12(4): 29-38.


Supervision of Thesis
Supervisor for 11 Ph.D. theses (7 were discussed)
1. Role of hypermethylation in RASSF1A & protocadherin-10 promoters in Egyptian breast cancer Patients as molecular diagnostic marker. (Discussed 2012).
2. Study of cyclin D1 and p73 polymorphisms in Egyptian breast cancer patients as molecular diagnostic markers.( Discussed 2012) .
3. Serum nitric oxide (NO), tumour necrosis factor Alpha (TNF-alpha) ,basic fibroblast growth factor (BFGF) and copper as prognostic and angiogenic markers in breast cancer patients,(Discussed 2008).
4. Study vascular cell adhesion molecule-1 (VCAM-1) and leptin as angiogenic markers in breast cancer patients: evaluation of the the therapeutic effect of "shark care" drug as an angiogenic inhibitor (Discussed 2006).
5. Plasma insulin like growth factor -1 (IGF-1) and its protein -3 (IGFBP-3) in relation to sex hormones in postmenopausal patients with breast cancer receiving Tamoxifen with and without vitamin A (Discussed 2003).
6. Biophysical effect of electromagnetic field on some tissues of mice exposed to gamma ray and injected with 5-fluorouracil (Discussed 2001).
7. Effect of two chemotherapeutic regimens on some biochemical and immunological aspects in breast cancer patients (Discussed 1997)
8. Study Of Vitamin D Receptor In Breast Cancer Tissues And Its Relation To Estrogen Receptor alpha (α) mRNA Expression And Serum Vitamin D Level In Egyptian Breast Cancer Females. ” 2011- ……“
9. A genomic study on chemo-resistance in Egyptian breast cancer patients. :2010-…….
10. Accelerated partial breast irradiation “A comprehensive presentation “ The Taghan Technique Of 3 D Conformal Radiation therapy.(in collebration with Institute Gustave Roussy ,Faculty of Medicine, Paris University ,France.)”2009…. “
11. Evaluation of the impact of implementing pharmaceutical care for Egyptian oncology patients receiving chemotherapy . .(in collebration with Faculty of Pharmacy , Helwan University ,2013………
Supervisor for 30 Master degree theses (20 were discussed)
1. Study of serum Bcl-2 and P53 proteins as biological markers in breast cancer patients.( Discussed 2012 )
2. The role of sFAS and sFAS Ligand as biological markers in breast cancer patients. (Discussed 2012).
3. Evaluation of the role of tissue inhibitor of matrix metalloproteinase 1(TIMP-1) in vascular endothelial growth factor (VEGF) induction and their role in prognosis of breast cancer patients. (Discussed 2011).
4. Molecular and immunological study on breast cancer patients. (Discussed 2011).
5. Modeling Segmental and Total Bone Density after adjuvant treatment in women with non metastatic breast cancer. (Discussed 2011).
6. Evaluation of the role of circulating tumour cells (CTCs) as a prognostic marker and predictor of metastasis in breast cancer females (Discussed 2010).
7. Arm lymphedema following therapy for breast cancer: Incidence, risk factors and various procedures of management , (Discussed 2010).
8. Study of plasma adiponectin level in relation to insulin resistance in obese postmenopausal women with breast cancer (Discussed 2009)
9. Evaluation of the radioprotective effect of green tea extract in Gamma-Irradiated mice (Discussed 2008).
10. Comparative study between serum tissue polypeptide specific antigen (TPS) and serumCA15.3 related to the activity of antioxidant enzyme superoxide dismutase in the diagnosis and prognosis of breast cancer patients treated with surgery and chemotherapy (Discussed 2007).
11. Study the diagnostic and prognostic value of prostate specific antigen (PSA) .CA15.3 and the activity of total acid and alkaline phosphatases in serum of breast cancer female patients (Discussed 2006).
12. Blood glutathione s transferase activity and level of soluble intracellular adhesion molecule -1 (sICAM-1) in serum of breast cancer patients before and after treatment. (Discussed 2006)
13. Radioimmunoassay (RIA) of plasma glutathione-s- transferase - PI (GST-PI) as a tumour marker in hepatocellular carcinoma (HCC) (Discussed 2003).
14. Effect of treatment with chemotherapy (CMF) with and without antioxidant supplementation on the antioxidant capacity in breast cancer patients (Discussed 2001).
15. The clinical value of serum lactate dehydrogenase, ceruloplasmin, cathepsin-D and lipid-bound sialic acid in monitoring patients with malignant lymphomas (Discussed 1997).
16. Alpha fetoprotein and hepatitis B virus markers in relation to liver cirrhosis and to hepatocellular carcinoma during chemotherapy (Discussed 1996).
17. A correlation between MDR1 gene methylation status and genetic polymorphism(s) in some Egyptian female primary breast cancer patients.(2012…….
18. Ki-67 Expression as a prognostic marker in breast cancer with relation to serum C A .15-3.(2011-……
19. Study of vitamin D receptor polymorphism among Egyptian breast cancer patients.(2011-……..
20. Study of the role of serum resistin, sex hormone binding globulin, insulin and free estradiol in postmenopausal breast cancer patients.(2011-….
21. Study of serum 25- hydroxyvitamin D and calcium in Egyptian breast cancer females. (2011-2013)
22. Genetic polymorphism in PER 3 circadian gene and susceptibility to breast cancer.(2011-…..
23. The role of ginger as a chemopreventive and radioprotective agent in mice bearing mammary tumors.(2011-……….
24. Molecular Diagnosis of Melatonin Receptor Polymorphism among Egyptian Breast Cancer Patients. (2011-2013)
25. Prognostic Study of STAT 3 in breast cancer patients .(2011-……
26. 10 years follow up in breast cancer patients with axillary lymph node negative and /or 1-3 positive lymph node treated with or without regional radiotherapy .(2010-2013)
27. Prodigiosin isolation, identification and study of its biotechnological application.(2010-…….
28. Matrix Metalloprotinase-8 and E-Cadherin in patients with breast cancer (2010 -2013)
29. Matrix Metalloprotinase-8 and IL-12 in patients with breast cancer (2011-….
30. Analysis and treatment outcome of Hodgkin lymphoma patients, ten years experience of Faculty of Medicine and Medical Research Institute, Alexandria university (2013-…….


Experiences
1 Participation in the Project with Bibilotica Alexandria &Intel. from 2013-…
"Handwritting in detection of cancer"This project has awarded The 1st Project award March 2013.
2 Head of the session for the 1st Scientific Meeting of the Scientific Commetee, Medical Research Institute ,Alexandria University,Titled "OBESITY"ai 14-2-2013.
3 Participation in the Project: Proteomic and Genomic analysis of BRCA1 Gene in Egyptian Breast Cancer. from 2008 -2010 .
4 Participation in the Project: Molecular Detection of presymptomatic breast cancer in females from Jan 2006-2008.
5 Attendance of 18 credit hours of CME (Recent advances in Oncology) 5-7th Dec 2007.
6 Attended the course of the European School of Oncology "Innovations in Cancer Management" Alexandria, Egypt. 13-15th Oct 1999.
7 Attended a training course in "Uses and Protection against Ionizing Radiation". 1st-30th Dec. 1990.
8 Member of the Surgical oncology , Radiotherapy, medical oncology and nuclear medicine committee of assistant professors and professors promotion in the Egyptian universities ,Ministry of High Education ,Egypt "Committee No 83".(2008-2012).
Member of the Surgical oncology , Radiotherapy, medical oncology and nuclear medicine High Committee of assistant professors and professors promotion in the Egyptian universities ,Ministry of High Education ,Egypt."Committee No 83 " (Jan.2013-Current......

9 Member in scientific societies
• Anti-Cancer and Patient's Care Association in Alexandria-Egypt.
• Arab association of Cancer Registration and Control (AACRC).
• Arab Council against Cancer.
• Egyptian Cancer Society.
• Breast gynecologic International Cancer Society
9-Attended and passed the courses of ICDL program 2010.
10-Attended and passed the courses of ICTP and Photoshop programs 2008.

Examiner:
• Sharing as member of Examiners Committee for most of theses that I was one of the Supervisors Committee
• Sharing as member of Examiners Committee for MD degree of Radiotherapy & Nuclear Medicine ,Faculty of Medicine ,Alexandria University ,November 2012.
• Sharing as member of Examiners Committee For PhD Degree Titled "study on improving the electrochemotherapy process applying the various parameters of the pulsating electric field. Submitted to Department of Medical Biophysics , Medical Research Institute, University of Alexandria, Egypt, 2012.
• Sharing as member of Examiners Committee For PhD Degree Titled “Comparative study on the efficiency of using pulsed and direct current electric fields combined with a cytotoxic drug in treating ehrlich tumor “ Submitted to Department of Medical Biophysics , Medical Research Institute, University of Alexandria,Egypt, 2009.
• Sharing as member of Examiners Committee For MS Degree Titled “Polymorphism of some DNA repair genes in some breast cancer cases in Egypt” Submitted to Department of Biotechnology , Institute of Graduate Studies and Research ,University of Alexandria,Egypt. 2011.
• Sharing as member of Eligability test for PhD Student At Medical Research Institute.,University of Alexandria, Egypt. June 2012.
• Sharing as member of Eligability test for PhD Student At Institute of Graduate Studies and Research, University of Alexandria, Egypt. January 2011.



Others
Awards and publications
Main Supervisor for 3 student ( Grade 11& 12)who won the 1st Grand Award in the Intel Bibiliotheca Alexandrina Science and Engineering Fair ( IBASEF) On a project:
( New Screening Method for Early Pediatric Cancer Detection Through Automated Handwriting Analysis).
"This project represented EGYPT in the Intel International Science and Engineering Fair ( Intel ISEF), which took place in the United States of America in May 2013 and won Intel ISEF 2013 Grand Award Winners fourth place.

• The Egyptian Association of Advancement of Medical Basic Sciences ,Faculty of Medicine ,Alexandria University, I got a Certificate of achievement for my paper " Hewala TI, Abd El-Moneim NA, Ebied SA, Sheta MI, Soliman K, Abu–A Elenean. Diagnostic and prognostic value of serum nitric oxide, tumor necrosis factor–α, basic fibroblast growth factor and copper as angiogenic, markers in premenopausal breast cancer patients : a case control study. J Br Biomed Sci 2010; 67(4):167-76. May 2013.



• I won award with my co authers :BGICS Research 1st award for the poster titled: Elalfy E, Abd El-Moneim NA, Khalil SA. Impact of comorbidity, hormonal receptor status and Adjuvant chemotherapy plus tamoxifen versus tamoxifen, alone on survival of senior breast cancer patients: retrospective study Updated Data .Poster Presentation:.in 5Th Breast – Gynacological International Cancer Conference BGICS ) ,17-18 January 2013, Fairmont Towers Hotel,Cairo,Egypt.The poster was recognized as the best research in the conference & got BGICS Research 1st award .

• I won award for international publication from University of Alexandria, in January 2011 for the paper published in journal of british Biomedical science titled (Hewala TI, Abd El-Moneim NA, Ebied SA, Sheta M I ,Soliman K and Abu –A. Elenean .Diagnostic and prognostic value of serum nitric oxide ,tumor necrosis factor–α ,basic fibroblast growth factor and copper as angiogenic.markers in premenopausal breast cancer patients : a case control study J Br Biomed Sci 2010 ; 67(4) ; 167-76.
• I won Award in International Conference of Joint Meeting of the American Society Oncology (ASCO) and PAN ARAB which was held in Cairo 9-11 Nov 1999 for my article titled:
"Granulocyte-Macrophage (Colony-stimulating factor (GM-CSF) and interleukin-3 (IL-3) in Hodgkin's disease before and after treatment". the Egyptian Journal of Immunology 1999; 6(2):85-93.
• Author of "Medical Oncology" Book published in Arabic language by the Ministry of Health and Population in association with World Health Organization 2006. The book is taught to students of (Oncology Department),Technical Health Institutes.
• I was chosen to be a Reviewer in Science and Technology Development Fund To evaluate the international projects . I have reviewed many projects since 2010.




Author of "Medical Oncology" Book published in Arabic language by the Ministry of Health and Population in association with World Health Organization 2006. The book is taught to students of (Oncology Department),Technical Health Institutes.



Alexandria University Alexandria University